Chris is the former head of Neuroscience at Amgen and former VP of Neuroscience and LRL Europe at Eli Lilly and Company. Chris recently retired from Biovail Laboratories where he was their Chief Science Officer.

Terry is a professor of Biochemistry and Microbiology at the University of Victoria. Following postdoctoral work in the laboratory of Nobel Laureate Dr. Sydney Brenner, he was involved in the early stages of the development of monoclonal antibody technology.

Mike is a partner at the firm of Smith Hutchison and acts for biOasis Advanced Technologies Inc.